Monopar Announces Presentation Selected for 2022 Connective Tissue Oncology Society (CTOS) Annual Meeting Oct 12, 2022
Monopar Announces Completion of Phase 2b Enrollment and Commencement of Phase 3 Enrollment in its VOICE Trial for Severe Oral Mucositis Oct 5, 2022
Monopar Therapeutics Reports Second Quarter 2022 Financial Results and Recent Program Developments Aug 11, 2022
Monopar Therapeutics Reports First Quarter 2022 Financial Results and Recent Program Developments May 12, 2022
Monopar Therapeutics Reports Fourth Quarter and Full-Year 2021 Financial Results and Recent Program Developments Mar 24, 2022
Monopar to Present at the 34th Annual Roth Conference and Maxim’s 2022 Virtual Growth Conference Mar 8, 2022
Monopar Advances Dosing of Camsirubicin to Higher Level Than Tested In Any Previous Clinical Trial Dec 8, 2021
